Copaiba oil as an adjuvant the treatment of pulmonary tuberculosis

• Autor: Hernández-Panduro, Otilia
• Formato: artículo
• Fecha de Publicación: 2019
• Institución: Universidad Nacional Hermilio Valdizan
• Repositorio: Revistas - Universidad Nacional Hermilio Valdizán
• Lenguaje: español
• OAI Identifier: oai:revistas.unheval.edu.pe:article/997
• Enlace del recurso: http://revistas.unheval.edu.pe/index.php/gacien/article/view/997
• Nivel de acceso: acceso abierto
• Materia: aceite de copaiba; coadyuvante; tratamiento de tuberculosis; copaiba oil; adjuvant; treatment of tuberculosis

Therapeutic effects of copaiba oil as an adjunct to the treatment of pulmonary tuberculosis, the experimental group copaiba oil more drug treatment and drug treatment control group was administered; quantitative application, longitudinal, prospective and experimental techniques used: questionnaire, interview and record observation guide. Were analyzed using SPSS, and statistical calculation was square CHI for possible correlations between the different variables and the mean difference before and after the program. Condence interval of 95 % was used. <0.05 were signicant. The outcome of treatment is the best kind to help reduce normal secretion and 4(11%) of patients with mild malnutrition and 1(3%) moderate malnutrition. The post test control group we observed 27 (76%) mild malnutrition treatment based copaiba oil capsules to the experimental group, 32 ( 89%) patients have preserved lung eld, 4 ( 11%) as mild sequelae parenchymal opacity, residual tract caverns dim parenchymal opacity. Control 36(100 %) group continued to have sequels. Nutritional status after administration of copaiba oil in the experimental group 31(86%) normal nutritional status, 6(16%) had moderate malnutrition in the smear test experimental group in the post test 36(100%) no registered smear positive , the control group 2(7.2 %) recorded positive smear with a + . The statistical test was signicant at α = 5 % critical value of the statesman of the table is α χ ² = 3.841; since 57.6 > 3.841 reject the null hypothesis and accept the research hypothesis. Hypothesized patients receiving therapeutic copaiba oil supplement for 6 months improved biological reactions compared to the control group who received drug therapy is checked.